The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?

BACKGROUND Somatostatin (SST) analogues represent a novel approach for the treatment of certain cancers. The objective of this article is to summarise the current knowledge on SST analogues in the treatment of cancer patients. METHODS Computerised (Medline) and manual searches were performed to identify publications on clinical trials published in the English-speaking literature between 1966 ...

Much ado about nothing?

I t all started with the submission of an unsolicited review on idiopathic pulmonary haemosiderosis by IOACHIMESCU et al. [1]. During the review process of this excellent manuscript, the idea evolved to launch a whole series on rare (orphan) interstitial lung disorders in the European Respiratory Journal. Why bother? Well, admittedly, these diseases are rare, but for the affected patient that d...

Much ado about nothing?

Much ado about nothing.

Much ado about nothing.